[{"id":"6b7343bd-05b1-474c-8d36-fe39eab91743","acronym":"MM FPBMC","url":"https://clinicaltrials.gov/study/NCT04864522","created_at":"2021-04-29T12:55:37.907Z","updated_at":"2024-07-02T16:35:28.423Z","phase":"Phase 1/2","brief_title":"Phase I/II Study of SLAMF7 FPBMC/CS-1 FPBMC in Relapsed/Refractory Multiple Myeloma","source_id_and_acronym":"NCT04864522 - MM FPBMC","lead_sponsor":"University of Virginia","biomarkers":" SLAMF7","pipe":"","alterations":" ","tags":["SLAMF7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e SLAMF7 FPBMC"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 08/01/2023","start_date":" 08/01/2023","primary_txt":" Primary completion: 11/01/2023","primary_completion_date":" 11/01/2023","study_txt":" Completion: 11/01/2023","study_completion_date":" 11/01/2023","last_update_posted":"2023-11-21"}]